Neoplasms, Colorectal Recruiting Phase 3 Trials for Bevacizumab (DB00112)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02885753Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the LiverTreatment
NCT03303495A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRCTreatment